(CIDRAP News) – The World Health Organization (WHO) has called a Nov 11 "summit" meeting of health officials and vaccine companies to discuss how to confront what is seen as the growing risk that avian influenza will trigger a human flu pandemic.
(CIDRAP News) The Swiss drug company Roche has pledged to give the World Health Organization (WHO) enough doses of the antiviral drug oseltamivir (Tamiflu) to treat 3 million people, in the hope that it could help to stave off or delay an influenza pandemic.
(CIDRAP News) A group of influenza experts convened by the World Health Organization cautioned today that governments shouldn't stockpile "pre-pandemic" H5N1 influenza vaccines now, because too little is known about the requirements for an effective vaccine.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
The World Health Organization's (WHO's) global count of confirmed swine flu cases stands at 257 cases in 11 countries today. The United States has 109 cases and 1 death; Mexico has 97 cases and 7 deaths. [WHO update 6]
The World Health Organization (WHO) reported 331 cases of swine influenza H1N1 in 11 countries as of 6 a.m. GMT today. The case numbers by country are United States, 109 (1 death) (these are yesterday's totals); Mexico, 156 (9 deaths), Canada, 34; Spain, 13; United Kingdom, 8; New Zealand, 3; Germany, 3; Israel, 2; and 1 each in Austria, the Netherlands, and Switzerland. [WHO update 7]
(CIDRAP News) Against the backdrop of a global struggle to solve a dispute related to H5N1 avian influenza virus sharing and an anxious watch over the novel H1N1 virus sweeping the globe, a new public database for sharing influenza genetic sequences is easing the flow of data and winning the support of a growing community of researchers and health officials, even some from countries that have sparred in the past over intellectual property rights.